Level 4 evidence is relevant to case-series studies that focus on therapy, prevention, etiology, and harm
Brand-name availability exists primarily as an alternative for patients concerned about the safety and quality differences between compounded and FDA-approved medications
[14] Later developments were done by M3 Biotechnology, a company founded to commercialize dihexa
Standard / Gradual Approach There is no titration schedule for Dihexa in humans, because human absorption, metabolism, and the therapeutic window are simply unknown
While both peptides are classified as growth hormone secretagogues, they are often chosen for different research goals
Additionally, Troponin-I levels were significantly reduced in the L-carnitine group relative to the control group 8 h after percutaneous coronary intervention (PCI) (Xue et al